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http://dx.doi.org/10.1016/j.jfma.201Background/Purpose: Patients with thalassemia trait (TT) may have anemia. This study evalu-
ated whether TT patients had specific oral manifestations and a particular blood profile
compared with normal individuals.
Methods: The oral manifestations and mean red blood cell count, corpuscular cell volume, red
blood cell distributionwidth, Mentzer index, and Green and King index aswell as blood concentra-
tions of hemoglobin, iron, total iron binding capacity, vitamin B12, folic acid, and homocysteine in
65 TT patients and in 130 age- and sex-matched healthy controls were measured and compared.
Results: TT patients had significantly higher frequencies of all oral manifestations than healthy
controls (p < 0.001 for all), in which burning sensation of oral mucosa (90.8%), lingual varicosity
(90.8%), dry mouth (72.3%), atrophic glossitis (32.3%), and numbness of the oral mucosa (30.8%)
were the five leading oral manifestations for TT patients. Moreover, TT patients had significantly
lower mean hemoglobin level, corpuscular cell volume, Mentzer index, and Green and King index
(p < 0.001 for all) as well as significantly higher mean red blood cell count and red blood cell dis-
tributionwidth (p< 0.001 for both) thanhealthycontrols. However, no significant difference in the
mean blood iron, total iron binding capacity, vitamin B12, folic acid, or homocysteine levels was
discovered between 65 TT patients and 130 healthy controls.
Conclusion: TT patients have specific oral manifestations and a particular blood profile compared
to normal individuals.
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dividuals were selected. Thus, the normal control groupThalassemia is an autosomal recessive blood disorder in
which the body makes an abnormal form of hemoglobin
(Hb). Hb is composed of four protein chains, two a and
two b globin chains arranged into a heterotetramer. The
a globin chains are encoded by two closely linked genes
on chromosome 16 and the b globin chains are encoded
by a single gene on chromosome 11. There are two main
types of thalassemia: a-thalassemia occurs when a gene
or genes related to the a globin protein are missing or
mutated, and b-thalassemia occurs when similar gene
defects affect production of the b globin protein. Both
a- and b-thalassemias include the following forms: thal-
assemia major (with the defective genes from both par-
ents); and thalassemia minor (with the defective gene
from only one parent). The most severe form of a-thal-
assemia major causes stillbirth. Children born with thal-
assemia major may be normal at birth, but develop
severe anemia during the first year of life. Other symp-
toms and signs include bone deformities in the face, fa-
tigue, growth failure, shortness of breath, and yellow
skin (jaundice). Patients with the minor form of a- or b-
thalassemia often have hypochromic and microcytic
anemia, but usually have no apparent systemic
symptoms.1
Hb is the protein in red blood cells (RBCs) that carries
oxygen. People with thalassemia make more abnormal
forms of a-globin chain, b-globin chain, and Hb compared
to normal individuals. Imbalances of globin chains cause
hemolysis, which results in mild to severe anemia.1 Pa-
tients with anemia may have atrophic glossitis (AG) or
generalized oral mucosal atrophy and tenderness or
burning sensation of oral mucosa.2 However, it is still not
known whether patients with thalassemia trait (TT
including a- or b-thalassemia minor) may have specific oral
manifestations and what percentages of TT patients may
have the oral manifestations. In this study, 65 TT patients
were collected from the oral mucosal disease clinic of
National Taiwan University Hospital (NTUH). Their oral
manifestations [including burning sensation and numbness
of oral mucosa, dry mouth, dysfunction of taste, lingual
varicosity, AG, recurrent aphthous ulcerations (RAU), and
oral lichen planus (OLP)], complete blood count, and blood
chemistry (including blood levels of Hb, iron, vitamin B12,
folic acid, and homocysteine) were inquired, examined,
and recorded. These data were compared with corre-
sponding data in 130 age- and sex-matched healthy con-
trols without oral mucosal and systemic diseases to assess
whether TT patients had higher frequencies of specific oral
manifestations and a particular blood profile compared to
healthy controls.Materials and methods
Participants
The study group consisted of 65 TT patients (14 men and
51 women; age range 20e88 years, mean 56.2  14.4
years). For each patient, two age- (2 years of eachpatient’s age) and sex-matched healthy control in-
consisted of 130 healthy participants (28 men and 102
women, age range 21e89 years, mean 55.1  14.4 years).
All patients and healthy controls were seen consecutively,
diagnosed, treated, and selected in the oral mucosal
disease clinic of NTUH from July 2007 to June 2013. Pa-
tients were diagnosed as having TT when they had RBC
count >5.0  1012/L,3 mean corpuscular volume (MCV)
<74 fL,4 Mentzer index (MCV/RBC) <13,5 and Green and
King (G&K) index [MCV2  RDW/(Hb  100)] <65.6 Burning
mouth syndrome (BMS) was diagnosed when patients had
a burning sensation of the oral mucosa in the absence of
clinically apparent mucosal alterations.7 Patients were
diagnosed as having partial or complete AG when their
dorsal tongues showed partial or complete absence or
flattening of filiform papillae, respectively.8 RAU was
diagnosed when patients had at least one episode of oral
ulcerations per month during the preceding years.9 OLP
was diagnosed according to the following criteria: (1) a
typical clinical presentation of radiating grayishewhite
Wickham striae or papules (nonerosive OLP) combined
with erosion or ulceration on the bilateral buccal or
vestibular mucosa (erosive OLP or EOLP); and (2) biopsy
specimens characteristic of OLP, that is: hyperkeratosis or
parakeratosis, a slightly acanthotic epithelium with
liquefaction degeneration of the basal epithelial cells, a
pronounced band-like lymphocytic infiltrate in the lamina
propria, and the absence of epithelial dysplasia.10e12
However, all TT patients with areca quid chewing habit,
autoimmune diseases (such as systemic lupus erythema-
tosus, rheumatoid arthritis, Sjøgren’s syndrome,
pemphigus vulgaris, and cicatricial pemphigoid), inflam-
matory diseases, malignancy, or recent surgery were
excluded. In addition, all TT patients with serum creati-
nine concentrations indicative of renal dysfunction (i.e.,
men, >131 mM; women, >115 mM), and who reported a
history of stroke, heavy alcohol use, or diseases of the
liver, kidney, or coronary arteries were also excluded.13
Healthy controls had either dental caries or mild peri-
odontal diseases but did not have any oral mucosal or
systemic diseases. None of our TT patients had taken any
prescription medication for BMS, AG, RAU, or OLP for at
least 3 months before entering the study.
According to the aforementioned diagnostic criteria,
the 65 TT patients included 31 (4 men and 27 women;
mean age, 54.0 years) with BMS, 19 (4 men and 15 women;
mean age, 61.8 years) with AG, seven (3 men and 4
women; mean age, 50.4 years) with EOLP, six (2 men and 4
women; mean age, 55.9 years) with RAU, and two (1 man
and 1 woman; mean age, 58 years) with both RAU and AG.
For all TT patients and healthy controls, oral manifesta-
tions including burning sensation and numbness of oral
mucosa, dry mouth, dysfunction of taste, lingual varicos-
ity, AG, RAU, and OLP were inquired, examined and
recorded. The blood samples were drawn from all patients
and healthy controls for measurement of complete blood
count, blood iron, vitamin B12, folic acid, and homocys-
teine concentrations. All patients and healthy controls
signed informed consent before entering the study. This
study was reviewed and approved by the Institutional Re-
view Board at the NTUH.
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iron, vitamin B12, folic acid and homocysteine
concentrations
The complete blood count and blood iron, vitamin B12, folic
acid, and homocysteine concentrations were determined
by the routine tests performed in the Department of Lab-
oratory Medicine of NTUH.
Statistical analysis
Comparisons of the mean RBC count, MCV, RDW, Mentzer
index, and G&K index as well as mean blood levels of Hb,
iron, total iron binding capacity (TIBC), vitamin B12, folic
acid and homocysteine between 65 TT patients and 130
age- and sex-matched healthy controls were performed by
Student t test. The differences in frequency of hemoglobin
deficiency or of abnormally high blood homocysteine level
between 65 TT patients and 130 age- and sex-matched
healthy controls were compared by Chi-square test. In
addition, the difference in frequency of each oral mani-
festation between 65 TT patients and 130 age- and sex-
matched healthy controls were also compared by
Chi-square test. The result was considered to be significant
if the p-value was <0.05.
Results
The mean RBC count, MCV, RDW, Mentzer index, and G&K
index as well as blood concentrations of Hb, iron, TIBC,
vitamin B12, folic acid, and homocysteine in 65 TT patients
and in 130 age- and sex-matched healthy controls areTable 1 The mean  standard deviation (SD) red blood cell (RB
distribution width (RDW), Mentzer index, and Green and King (G&
(Hb), iron, total iron binding capacity (TIBC), vitamin B12, folic aci
and in 130 age- and sex-matched healthy controls.
Patients with thalassemic trait (nZ 65)
Mean  SD Range
Hb (g/dL)
Men 12.7  1.3 (n Z 14) 9.3e13.9
Women 11.7  0.8 (n Z 51) 9.5e13.3
RBC (1012/L) 5.8  0.4 5.1e6.9
MCV (fL) 66.1  3.5 57.9e72.7
RDW (%) 15.5  0.8 13.6e18.0
Mentzer index 11.5  1.0 9.4e12.9
G&K index 56.8  5.1 45.6e64.7
Iron (mg/dL)
Men 98.9  25.6 (n Z 14) 65.0e160.0
Women 96.8  24.0 (n Z 51) 60.0e140.0
TIBC (mg/dL) 301.2  35.6 203.0e407.0
Vitamin B12 (pg/mL) 654.9  255.6 250.0e1000.0
Folic acid (ng/mL) 13.6  6.8 4.5e24.0
Homocysteine (mM) 8.7  2.5 4.5e16.2
*Comparisons of the mean RBC count, MCV, RDW, Mentzer index, an
vitamin B12, folic acid, and homocysteine between 65 TT patients a
index Z MCV/ RBC; G&K index Z MCV2  RDW/(Hb  100).shown in Table 1. Because men usually had higher blood
levels of Hb and iron than women, these two mean levels
were calculated separately for men and women. We found
that TT patients had significantly lower mean Hb level
(p < 0.001 for both men and women), MCV (p < 0.001),
Mentzer index (p < 0.001), and G&K index (p < 0.001) as
well as significantly higher mean RBC count (p < 0.001) and
RDW (p < 0.001) than healthy controls (Table 1). However,
no significant difference in the mean blood iron, TIBC,
vitamin B12, folic acid, or homocysteine level was discov-
ered between 65 TT patients and 130 healthy controls
(Table 1).
According to the World Health Organization criteria,
men with hemoglobin <13 g/dL and women with hemo-
globin <12 g/dL are defined as having hemoglobin defi-
ciency or anemia.14 Furthermore, patients with serum iron
level <60 mg/dL,15 serum vitamin B12 level <200 pg/mL
(148 pM),13 or folic acid level <4 ng/mL (10nM)16 are
defined as having iron, vitamin B12, or folic acid deficiency,
respectively. In addition, patients with the blood homo-
cysteine level > 12.4 mM (which was the mean blood ho-
mocysteine level of healthy controls plus two standard
deviations) were defined as having abnormally high homo-
cysteine level. By the above-mentioned definitions, 32
(49.2%, 5 men and 27 women) of 65 TT patients and none of
the normal controls were diagnosed as having Hb deficiency
or anemia. Thus, TT patients had a significantly higher
frequency of Hb deficiency than healthy controls
(p < 0.001). However, none of TT patients or normal con-
trols were diagnosed as having iron, vitamin B12 and folic
acid deficiencies by the aforementioned strict World Health
Organization criteria. In addition, 6 (9.2%) TT patients and 3
(2.3%) normal controls had abnormally high bloodC) count, mean corpuscular cell volume (MCV), red blood cell
K) index as well as mean blood concentrations of hemoglobin
d, and homocysteine in 65 patients with thalassemic trait (TT)
Healthy controls (n Z 130) p Student t test
Mean  SD Range
15.1  0.6 (n Z 28) 13.8e16.3 <0.001*
13.6  0.7 (n Z 102) 12.2e15.2 <0.001*
4.6  0.4 3.9e6.7 <0.001*
90.9  3.3 82.4e98.6 <0.001*
12.9  0.6 11.7e15.1 <0.001*
19.8  1.9 13.4e25.1 <0.001*
77.5  6.4 65.2e90.1 <0.001*
99.4  23.7 (n Z 28) 65.0e151.0 0.990
96.2  26.1 (n Z 102) 60.0e204.0 0.891
307.0  32.6 228.0e384.0 0.258
655.4  220.9 259.0e1000.0 0.989
13.6  5.6 4.1e24.0 1.000
8.4  2.0 4.3e13.4 0.366
d G&K index as well as blood concentrations of Hb, iron, TIBC,
nd 130 healthy controls by Student t test with p <0.05. Mentzer
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ence in blood homocysteine level between TT patients and
normal controls (p Z 0.07).
The oral manifestations in 65 TT patients and in 130
healthy controls are shown in Table 2. TT patients had
significantly higher frequencies of all oral manifestations
than healthy controls (p < 0.001 for all), in which burning
sensation of oral mucosa (90.8%), lingual varicosity (90.8%),
dry mouth (72.3%), atrophic glossitis (32.3%), and numbness
of the oral mucosa (30.8%) were the five leading oral
manifestations for TT patients (Table 2).Discussion
This study showed significantly higher frequencies of all
oral manifestations in TT patients than in healthy controls
(p < 0.001 for all). These oral manifestations included
burning sensation of oral mucosa (90.8%), lingual varicosity
(90.8%), dry mouth (72.3%), AG (32.3%), numbness of oral
mucosa (30.8%), dysfunction of taste (20.0%), RAU (12.3%),
and EOLP (10.8%). Our previous studies found burning
sensation of oral mucosa, lingual varicosity, dry mouth,
numbness of oral mucosa, and dysfunction of taste in 100%,
92.5%, 75.7%, 43.9%, and 19.8% of 399 BMS patients,
respectively,7 and in 100%, 98.9%, 79.0%, 57.4%, and 27.8%
of 176 AG patients, respectively.8 Because 47.6%, 32.3%,
12.3%, and 10.8% of our TT patients had concomitant BMS,
AG, RAU and EOLP, this could explain why our TT patients
had significantly higher frequencies of all oral manifesta-
tions including burning sensation of oral mucosa, lingual
varicosity, dry mouth, numbness of oral mucosa, and
dysfunction of taste than healthy controls. In addition, 32
(49.2%) of our 65 TT patients had anemia. Anemia patients
have reduced hemoglobins, which carry insufficient oxygen
to oral mucosa and finally results in atrophy of oral mu-
cosa.2 The atrophic oral mucosa could also partially explain
why a significant number of our TT patients had burning
sensation and numbness of oral mucosa and dysfunction of
taste. The reasons for BMS and AG patients having burning
sensation and numbness of oral mucosa, lingual varicosity,
dry mouth, and dysfunction of taste than healthy controls
may have been explained in detail in our previous papers.7,8Table 2 Oral manifestations in 65 patients with thalassemia trai
Oral manifestation Particip
Patients with thalassem
trait (n Z 65)
Burning sensation 59 (90.8)
Lingual varicosity 59 (90.8)
Dry mouth 47 (72.3)
Atrophic glossitis 21 (32.3)
Numbness 20 (30.8)
Dysfunction of taste 13 (20.0)
Recurrent aphthous ulcerations 8 (12.3)
Oral lichen planus 7 (10.8)
*Comparison of frequency of each oral manifestation between 65 pati
controls by Chi-square test with p <0.05.This study also found that TT patients had significantly
lower mean Hb level, MCV, Mentzer index, and G&K index
as well as significantly higher mean RBC count and RDW
than healthy controls. TT patients make abnormal a and b
globin chains, which are easily destructed, resulting in a
significantly reduced Hb level and MCV in TT patients.17e20
Moreover, Hb is a heterotetramer composed of two a and
two b globin chains. A TT patient usually carries an
abnormal form of either a or b globin chain. Different
combinations and quantities of normal and abnormal a and
b globin chains in different RBCs finally result in an elevated
mean RDW in TT patients.17e20 However, the bone marrow
hematopoietic function of TT patients may be nearly
normal; this thus leads to compensatory production of
many hypochromic and microcytic RBCs resulting in a
significantly higher mean RBC count in TT patients.17e20
Microcytic RBCs in TT patients was not due to iron defi-
ciency, because there was no significant iron deficiency in
our TT patients compared to healthy controls.
DNA sequencing of a and b globin chain genes to assess
whether there is presence of gene mutation or missing is
the most reliable method to diagnose both a- and b-thal-
assemias. However, DNA sequencing of a and b globin chain
genes needs a relatively long period of time. b-TT can also
be confirmed when patients have the HbA2 level >3.5% and
normal serum ferritin level.17,18 Nevertheless, determina-
tion of HbA2 and serum ferritin levels is also time-
consuming. To date, >10 discrimination indices have been
reported using RBC indices obtained by automated blood
count.17e20 Several authors calculated sensitivity and
specificity of these discrimination indices in differentiating
TT from iron deficiency anemia. However, none of these
indices has a sensitivity and specificity of 100% in prediction
of TT and iron deficiency anemia.17e20 This study adopted
the simple factors such as RBC count >5  1012/L, MCV
<74 fL, Mentzer index <13, and G&K index <65 to help
confirm the diagnosis of a- or b-TT. The latter two indices
were used because the Mentzer index was the first pro-
posed index, which was relatively reliable and very easy to
calculate (MCV/RBC)5 and the G&K index has been reported
to provide the highest reliabilities in differentiating b-TT
from iron deficiency anemia with the sensitivity of 85.0%
and specificity of 94.8% in Chinese children17 and thet and in 130 age- and sex-matched healthy control individuals.











ents with thalassemia trait and 130 age- and sex-matched healthy
Oral manifestations in thalassemia patients 765sensitivity of 84.8% and specificity of 83.8% in Palestinian
population.18 The accurate diagnosis rate should be very
high, because this study used four criteria to select TT
patients. In addition, the more criteria used, the higher the
accurate diagnosis rate.
The major problem of TT patients is the gene defect that
results in synthesis of abnormal forms of a or b globin chain
and Hb.1 Compared to healthy controls, TT patients usually
do not have higher frequencies of gastrointestinal defects
or the presence of gastric parietal cell autoantibodies
resulting in malabsorption of iron, vitamin B12 and folic
acid.17e21 This could explain why there was no significant
difference in the mean blood iron, vitamin B12, folic acid,
or homocysteine levels between the 65 TT patients and 130
healthy controls in this study.
Our results showed significantly higher frequencies of all
oral manifestations in TT patients than in healthy controls,
with burning sensation of oral mucosa, lingual varicosity,
dry mouth, AG, and numbness of the oral mucosa being the
five leading oral manifestations for TT patients. We also
found that TT patients had significantly lower mean Hb
level, MCV, Mentzer index, and G&K index as well as
significantly higher mean RBC count and RDW than healthy
individuals. We conclude that TT patients do have specific
oral manifestations and a particular blood profile compared
to normal controls.
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